Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-08 12:29 pm Purchase | 13G | PLIANT THERAPEUTICS INC PLRX | Laurion Capital Management LP | 3,583,567 5.980% | 3,583,567 (New Position) | View |
| 2024-02-08 12:29 pm Purchase | 13G | BIOMEA FUSION INC BMEA | Laurion Capital Management LP | 2,736,367 7.660% | 2,736,367 (New Position) | View |
| 2023-03-03 4:01 pm Purchase | 13G | Codiak BioSciences Inc. CDAK | Laurion Capital Management LP | 3,713,300 9.600% | 1,700,000 (+84.44%) | View |
| 2023-02-08 5:16 pm Sale | 13G | Research Alliance Corp. II RACB | Laurion Capital Management LP | 0 0.000% | -800,000 (Position Closed) | View |
| 2023-02-08 5:14 pm Purchase | 13G | PYXIS ONCOLOGY INC PYXS | Laurion Capital Management LP | 3,170,803 9.000% | 3,170,803 (New Position) | View |
| 2023-02-08 5:13 pm Purchase | 13G | Codiak BioSciences Inc. CDAK | Laurion Capital Management LP | 2,013,300 5.500% | 2,013,300 (New Position) | View |
| 2022-01-31 6:23 pm Purchase | 13G | Research Alliance Corp. II RACB | Laurion Capital Management LP | 800,000 5.200% | 800,000 (New Position) | View |